Form4insider filings, from the source

SEC Form 4 · accession 0001209191-15-067353

LA JOLLA PHARMACEUTICAL CO · LJPC

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Kevin C Tang
Director · 10% Owner
Period of report
Aug 19, 2015
Accepted (ET)
Aug 21, 2015 · 4:14 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000920465

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Aug 19, 2015P20,000$26.1338A2,642,130IBy LP
Common StockF1Aug 19, 2015P10,000$26.2585A2,652,130IBy LP
Common StockF1Aug 19, 2015P10,000$26.9782A2,662,130IBy LP
Common StockF1Aug 19, 2015P30,000$27.5899A2,692,130IBy LP
Common StockF1Aug 20, 2015P10,000$27.1685A2,702,130IBy LP
Common StockF1Aug 20, 2015P10,000$26.6583A2,712,130IBy LP
Common StockF1Aug 20, 2015P10,000$26.971A2,722,130IBy LP
Common StockF1Aug 20, 2015P10,000$26.8549A2,732,130IBy LP
Common StockF1Aug 20, 2015P10,000$26.5448A2,742,130IBy LP
Common StockF1Aug 21, 2015P10,000$25.7167A2,752,130IBy LP
Common StockF1Aug 21, 2015P10,000$26.728A2,762,130IBy LP
Common StockF1Aug 21, 2015P10,000$27.815A2,772,130IBy LP
Common StockF1Aug 21, 2015P10,000$28.2505A2,782,130IBy LP
Common StockF1Aug 21, 2015P10,000$29.9413A2,792,130IBy LP

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses